Actitud anestésica: cribado cardiológico y riesgo de hipertermia maligna ante el niño con miopatía.

Rubén Ferreras vega; Enriqueta Arévalo Asensio; María Dolores Méndez Marín; Paloma Rubio Pascual

doi:10.30445/rear.v14i8.1047

Authors

Rubén Ferreras vega Associate Physician. Pediatric anesthesia and resuscitation. October 12 Hospital, Madrid. Spain
Enriqueta Arévalo Asensio Associate Physician. Pediatric anesthesia and resuscitation. October 12 Hospital.
María Dolores Méndez Marín Associate Physician. Pediatric anesthesia and resuscitation. October 12 Hospital.
Paloma Rubio Pascual Head of the Pediatric Anesthesia, Resuscitation and Pain Therapy Service, 12 de Octubre Hospital, Madrid. Spain

DOI:

https://doi.org/10.30445/rear.v14i8.1047

Keywords:

anesthesia, miopathy, malignant hypertermia, core myophaties, central core

Abstract

Congenital myopathies are a heterogeneous group of muscle diseases of genetic origin, which present with progressive muscle weakness due to injury to the muscle fiber. On many occasions they are accompanied by other structural abnormalities, those with greater anesthetic involvement, respiratory, cardiac, or association with malignant hyperthermia .

Some patients require sedation or general anesthesia for diagnostic tests or surgical interventions, for this reason adequate screening is mandatory in the pre-anesthetic consultation. Cardiological risk and the association with malignant hyperthermia must be identified in order to reduce perioperative morbidity and mortality.

References

Rosenberg H, Davis M, James D, Pollock N, Stowell K. Malignant hyperthermia. Orphanet J Rare Dis . 2007 Apr 24;2:21. doi: 10.1186/1750-1172-2-21.

Hayes J Gurnaney H, Brown A, Litman RS. Malignant hyperthermia and muscular dystrophies. Anesth Analg 2009;109:1043–1048

Obata R, Yasumi Y, Suzuki A. Rabdomyolisis in association with Duchenne´s muscular dystrophy. Can J Anaesth 1999;46:564-566.

Takahashi H, Shimokawa M, Sha K. Sevoflorane can induce rhabdomyolysis in Duchenne´s muscular dystrophy. Masui 2002; 51:190-192.

Segura LG, Lorenz JD, Weingarten TN, et al. Anesthesia and Duchenne or Becker muscular dystrophy: review of 117 anesthetic exposures. Paediatr Anaesth. 2013;23(9):855–864.

Yemen TA, McClain C. Muscular dystrophy, anesthesia and the safety of inhalational agents revisited; again. Paediatr Anaesth. 2006;16(2):105–108.

Veyckemans F., Scholtes J.-L. Myotonic dystrophies type 1 and 2: anesthetic care. Pediatric Anesthesia. 2013;23(9):794–803).

Cassandrini D, Trovato R, Rubegni A, Lenzi S, Fiorillo C, Baldacci J, Minetti C, Astrea G, Bruno C, Santorelli FM, Congenital myopathies: clinical phenotypes and new diagnostic tolos Italian Network on Congenital Myopathies. Ital J Pediatr. 2016 Aug 31;42(1):78. doi: 10.1186/s13052-016-0289-9. PMID: 29141652 PMCID: PMC5688763

North kn, Wang CH, Clarke N, Jungbluth H, Vainzof M, Dowling JJ, Amburgey K, Quijano-Roy S, Beggs AH, Sewry C, Laing NG, Bönnemann CG, Approach to the diagnosis of congenital myopathies. Neuromuscul Disord. 2014 Feb;24(2):97-116. doi: 10.1016/j.nmd.2013.11.003. Epub 2013 Nov 18.

Berardo A, DiMauro S, Hirano M. A diagnostic algorithm for metabolic myopathies. Curr Neurol Neurosci Rep. 2010 Mar;10(2):118-26. doi: 10.1007/s11910-010-0096-4.

Ahmed ST, Craven L, Russell OM, Turnbull DM, Vincent AE.Diagnosis and Treatment of Mitochondrial Myopathies. Neurotherapeutics. 2018 Oct;15(4):943-953. doi: 10.1007/s13311-018-00674-4.

Darras BT, Urion DK, Ghosh PS 000 Sep 5 [updated 2018 Apr 26]. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2018.

Schieren M, Defosse J, Bohmer A, Wappler F, Gerbershagen MU.Anaesthetic management of patients with myopathies. Eur JAnaesthesiol 2017 Oct;34(10):641-649.

Iannaccone ST, Castro D. Congenital muscular dystrophiesand congenital myopathies. Continuum (Minneap Minn) 2013Dec;19(6 Muscle Disease):1509-1534

Parness J, Bandschapp O, Girard T. The myotonias andsusceptibility to malignant hyperthermia. Malignant hyperthermia and neuromuscular disease. Anesth Analg 2009Oct;109(4):1054-1064.

Moulds RFW, Denborough MA. Myopathies and malignant hyperpyrexia (Correspondence). Br Med J 1974; 3:520.

Britt BA, Kalow W. Malignant hyperthermia: a statistical review. Can Soc Anaesth Soc J 1970; 17:293–315.

Moulds RFW, Denborough MA: Myopathies and malignant hyperpyrexia (Correspondence) BrMed J 1974; 3:520.

Claeys KG. Congenital myopathies: an update. Dev Med Child Neurol. 2020;62(3):297–302)

Parness J, Bandschapp O, Girard T. The myotonias and susceptibility to malignant hyperthermia . Anesth Analg. 2009 Oct;109(4):1054-1064].

Bandschapp O, Iaizzo PA. Pathophysiologic and anesthetic considerations for patients with myotonia congenita or periodic paralyses. Paediatr Anaesth. 2013 Sep;23(9):824- 33. doi: 10.1111/pan.12217.

Litman RS,Griggs SM, James J. Dowling, M.D., Ph.D. ; Sheila Riazi, M.D. Malignant Hyperthermia Susceptibility and Related Diseases. Anesthesiology January 2018, Vol. 128, 159–167. https://doi.org/10.1097/ALN.0000000000001877).

Parness J., Bandschapp O., Girard T. The myotonias and susceptibility to malignant hyperthermia. Anesthesia & Analgesia. 2009;109(4):1054–1064)

Rosenberg H, Pollock N, Schiemann A, Bulger T, Stowell K. Malignant hyperthermia: a review. Orphanet J Rare Dis. 2015;10:93. Published 2015 Aug 4. doi:10.1186/s13023-015-0310-1)

J Niezgoda J, Morgan PG. Anesthetic considerations in patients with mitochondrial defects. Paediatr Anaesth. 2013 Sep;23(9):785-93. doi: 10.1111/pan.12158. Epub 2013 Mar 28.

Carpenter D, Ringrose C, Leo V, Morris A, Robinson RL, Halsall PJ, Hopkins PM, Shaw MA. The role of CACNA1S in predisposition to malignant hyperthermia. BMC Med Genet. Oct 13. 2009; 10: 104. doi: 10.1186/1471-2350-10-104

Shanahan H, O'Donoghue R, O'Kelly P, Synnott A, O'Rourke J. Preparation of the Drager Fabius CE and Drager Zeus anaesthetic machines for patients susceptible to malignant hyperthermia. Eur J Anaesthesiol. 2012 May;29(5):229-34. doi: 10.1097/EJA.0b013e328351b521.

ENLACES:

Enlace 1: Documento disponible en: https://www.sen.es/pdf/neuromuscular/miopatias_hereditarias.pdf

Enlace 2: https://www.orpha.net/data/patho/Ans/es/Distrofia-miotonica-1-y-2_ES.pdf